Not all patients with CLL call for therapy. Even with all new advances, the iwCLL however endorses watchful observation for sufferers with asymptomatic ailment.86 This advice is based on not less than two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Di segmen ini, https://edwardd715xhs1.tokka-blog.com/profile